Splenic irradiation as primary therapy for prolymphocytic leukemia

A patient with prolymphocytic leukemia (PLL), a lymphoproliferative disorder that carries a poor prognosis, is presented. The disease was diagnosed at an early stage and treatment could be delayed for four years. When massive, painful splenomegaly developed, splenic irradiation (SI) was chosen as th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Am. J. Hematol.; (United States) 1989-03, Vol.30 (3), p.188-189
Hauptverfasser: Kiss, A., Haubenstock, A., Bognar, H., Scheiderbauer, R., Ai‐Mobarak, M., Base, W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 189
container_issue 3
container_start_page 188
container_title Am. J. Hematol.; (United States)
container_volume 30
creator Kiss, A.
Haubenstock, A.
Bognar, H.
Scheiderbauer, R.
Ai‐Mobarak, M.
Base, W.
description A patient with prolymphocytic leukemia (PLL), a lymphoproliferative disorder that carries a poor prognosis, is presented. The disease was diagnosed at an early stage and treatment could be delayed for four years. When massive, painful splenomegaly developed, splenic irradiation (SI) was chosen as the primary form of therapy and an excellent systemic response could be achieved. Our observation is in agreement with preliminary studies, which advocate SI as the primary form of therapy in PLL. Furthermore, it is emphasized that an early diagnosis of PLL is necessary to establish its true course and that the prognosis may be better than originally thought.
doi_str_mv 10.1002/ajh.2830300313
format Article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_proquest_miscellaneous_78858633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78858633</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3963-b0cc9abe06aa74b376c63f73840b2509a0e02bbebb06d43d002cf178514f1da3</originalsourceid><addsrcrecordid>eNqFkLtPwzAQxi0EKqWwsiFFCLG1nO3EcUZAPIXEQHfr7DiqIY9ip0L573HVCNiY7nTf714fIacUFhSAXeH7asEkBw7AKd8jUwqFmEuRsX0yBS5ozKE4JEchvANQmkqYkAkrqMgEm5Kbt3VtW2cS5z2WDnvXtQmGZO1dg35I-pX1uB6SqvOx1tVDs151ZuhjR203H7ZxeEwOKqyDPRnjjCzv75a3j_OX14en2-uXueGF4HMNxhSoLQjEPNU8F0bwKucyBc0yKBAsMK2t1iDKlJfxOVPRXGY0rWiJfEbOd2O70DsVjOutWZmuba3pleCpzBiP0OUOird-bmzoVeOCsXWNre02QeVSZlLwLbjYgcZ3IXhbqfFjRUFtjVXRWPVrbGw4GydvdGPLH3x0MuoXo47BYF15bI0LP1hOqcjZFit22Jer7fDPUnX9_PjnhG9tpZCp</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78858633</pqid></control><display><type>article</type><title>Splenic irradiation as primary therapy for prolymphocytic leukemia</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kiss, A. ; Haubenstock, A. ; Bognar, H. ; Scheiderbauer, R. ; Ai‐Mobarak, M. ; Base, W.</creator><creatorcontrib>Kiss, A. ; Haubenstock, A. ; Bognar, H. ; Scheiderbauer, R. ; Ai‐Mobarak, M. ; Base, W. ; Univ. of Vienna (Austria)</creatorcontrib><description>A patient with prolymphocytic leukemia (PLL), a lymphoproliferative disorder that carries a poor prognosis, is presented. The disease was diagnosed at an early stage and treatment could be delayed for four years. When massive, painful splenomegaly developed, splenic irradiation (SI) was chosen as the primary form of therapy and an excellent systemic response could be achieved. Our observation is in agreement with preliminary studies, which advocate SI as the primary form of therapy in PLL. Furthermore, it is emphasized that an early diagnosis of PLL is necessary to establish its true course and that the prognosis may be better than originally thought.</description><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.2830300313</identifier><identifier>PMID: 2916562</identifier><identifier>CODEN: AJHEDD</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>550603 - Medicine- External Radiation in Therapy- (1980-) ; Biological and medical sciences ; BODY ; DISEASES ; Hematologic and hematopoietic diseases ; HEMIC DISEASES ; Humans ; IMMUNE SYSTEM DISEASES ; IRRADIATION ; LEUKEMIA ; Leukemia, Prolymphocytic - blood ; Leukemia, Prolymphocytic - radiotherapy ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; lymphoproliferative disorder ; Male ; Medical sciences ; MEDICINE ; Middle Aged ; NEOPLASMS ; NUCLEAR MEDICINE ; ORGANS ; PATIENTS ; polylymphocytic leukemia ; RADIOLOGY ; RADIOLOGY AND NUCLEAR MEDICINE ; RADIOTHERAPY ; SPLEEN ; Spleen - radiation effects ; splenic irradiation ; THERAPY</subject><ispartof>Am. J. Hematol.; (United States), 1989-03, Vol.30 (3), p.188-189</ispartof><rights>Copyright © 1989 Wiley‐Liss, Inc., A Wiley Company</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3963-b0cc9abe06aa74b376c63f73840b2509a0e02bbebb06d43d002cf178514f1da3</citedby><cites>FETCH-LOGICAL-c3963-b0cc9abe06aa74b376c63f73840b2509a0e02bbebb06d43d002cf178514f1da3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.2830300313$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.2830300313$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,882,1413,27906,27907,45556,45557</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7116722$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2916562$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/6348523$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Kiss, A.</creatorcontrib><creatorcontrib>Haubenstock, A.</creatorcontrib><creatorcontrib>Bognar, H.</creatorcontrib><creatorcontrib>Scheiderbauer, R.</creatorcontrib><creatorcontrib>Ai‐Mobarak, M.</creatorcontrib><creatorcontrib>Base, W.</creatorcontrib><creatorcontrib>Univ. of Vienna (Austria)</creatorcontrib><title>Splenic irradiation as primary therapy for prolymphocytic leukemia</title><title>Am. J. Hematol.; (United States)</title><addtitle>Am J Hematol</addtitle><description>A patient with prolymphocytic leukemia (PLL), a lymphoproliferative disorder that carries a poor prognosis, is presented. The disease was diagnosed at an early stage and treatment could be delayed for four years. When massive, painful splenomegaly developed, splenic irradiation (SI) was chosen as the primary form of therapy and an excellent systemic response could be achieved. Our observation is in agreement with preliminary studies, which advocate SI as the primary form of therapy in PLL. Furthermore, it is emphasized that an early diagnosis of PLL is necessary to establish its true course and that the prognosis may be better than originally thought.</description><subject>550603 - Medicine- External Radiation in Therapy- (1980-)</subject><subject>Biological and medical sciences</subject><subject>BODY</subject><subject>DISEASES</subject><subject>Hematologic and hematopoietic diseases</subject><subject>HEMIC DISEASES</subject><subject>Humans</subject><subject>IMMUNE SYSTEM DISEASES</subject><subject>IRRADIATION</subject><subject>LEUKEMIA</subject><subject>Leukemia, Prolymphocytic - blood</subject><subject>Leukemia, Prolymphocytic - radiotherapy</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>lymphoproliferative disorder</subject><subject>Male</subject><subject>Medical sciences</subject><subject>MEDICINE</subject><subject>Middle Aged</subject><subject>NEOPLASMS</subject><subject>NUCLEAR MEDICINE</subject><subject>ORGANS</subject><subject>PATIENTS</subject><subject>polylymphocytic leukemia</subject><subject>RADIOLOGY</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>RADIOTHERAPY</subject><subject>SPLEEN</subject><subject>Spleen - radiation effects</subject><subject>splenic irradiation</subject><subject>THERAPY</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkLtPwzAQxi0EKqWwsiFFCLG1nO3EcUZAPIXEQHfr7DiqIY9ip0L573HVCNiY7nTf714fIacUFhSAXeH7asEkBw7AKd8jUwqFmEuRsX0yBS5ozKE4JEchvANQmkqYkAkrqMgEm5Kbt3VtW2cS5z2WDnvXtQmGZO1dg35I-pX1uB6SqvOx1tVDs151ZuhjR203H7ZxeEwOKqyDPRnjjCzv75a3j_OX14en2-uXueGF4HMNxhSoLQjEPNU8F0bwKucyBc0yKBAsMK2t1iDKlJfxOVPRXGY0rWiJfEbOd2O70DsVjOutWZmuba3pleCpzBiP0OUOird-bmzoVeOCsXWNre02QeVSZlLwLbjYgcZ3IXhbqfFjRUFtjVXRWPVrbGw4GydvdGPLH3x0MuoXo47BYF15bI0LP1hOqcjZFit22Jer7fDPUnX9_PjnhG9tpZCp</recordid><startdate>198903</startdate><enddate>198903</enddate><creator>Kiss, A.</creator><creator>Haubenstock, A.</creator><creator>Bognar, H.</creator><creator>Scheiderbauer, R.</creator><creator>Ai‐Mobarak, M.</creator><creator>Base, W.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>198903</creationdate><title>Splenic irradiation as primary therapy for prolymphocytic leukemia</title><author>Kiss, A. ; Haubenstock, A. ; Bognar, H. ; Scheiderbauer, R. ; Ai‐Mobarak, M. ; Base, W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3963-b0cc9abe06aa74b376c63f73840b2509a0e02bbebb06d43d002cf178514f1da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>550603 - Medicine- External Radiation in Therapy- (1980-)</topic><topic>Biological and medical sciences</topic><topic>BODY</topic><topic>DISEASES</topic><topic>Hematologic and hematopoietic diseases</topic><topic>HEMIC DISEASES</topic><topic>Humans</topic><topic>IMMUNE SYSTEM DISEASES</topic><topic>IRRADIATION</topic><topic>LEUKEMIA</topic><topic>Leukemia, Prolymphocytic - blood</topic><topic>Leukemia, Prolymphocytic - radiotherapy</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>lymphoproliferative disorder</topic><topic>Male</topic><topic>Medical sciences</topic><topic>MEDICINE</topic><topic>Middle Aged</topic><topic>NEOPLASMS</topic><topic>NUCLEAR MEDICINE</topic><topic>ORGANS</topic><topic>PATIENTS</topic><topic>polylymphocytic leukemia</topic><topic>RADIOLOGY</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>RADIOTHERAPY</topic><topic>SPLEEN</topic><topic>Spleen - radiation effects</topic><topic>splenic irradiation</topic><topic>THERAPY</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kiss, A.</creatorcontrib><creatorcontrib>Haubenstock, A.</creatorcontrib><creatorcontrib>Bognar, H.</creatorcontrib><creatorcontrib>Scheiderbauer, R.</creatorcontrib><creatorcontrib>Ai‐Mobarak, M.</creatorcontrib><creatorcontrib>Base, W.</creatorcontrib><creatorcontrib>Univ. of Vienna (Austria)</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Am. J. Hematol.; (United States)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kiss, A.</au><au>Haubenstock, A.</au><au>Bognar, H.</au><au>Scheiderbauer, R.</au><au>Ai‐Mobarak, M.</au><au>Base, W.</au><aucorp>Univ. of Vienna (Austria)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Splenic irradiation as primary therapy for prolymphocytic leukemia</atitle><jtitle>Am. J. Hematol.; (United States)</jtitle><addtitle>Am J Hematol</addtitle><date>1989-03</date><risdate>1989</risdate><volume>30</volume><issue>3</issue><spage>188</spage><epage>189</epage><pages>188-189</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><coden>AJHEDD</coden><abstract>A patient with prolymphocytic leukemia (PLL), a lymphoproliferative disorder that carries a poor prognosis, is presented. The disease was diagnosed at an early stage and treatment could be delayed for four years. When massive, painful splenomegaly developed, splenic irradiation (SI) was chosen as the primary form of therapy and an excellent systemic response could be achieved. Our observation is in agreement with preliminary studies, which advocate SI as the primary form of therapy in PLL. Furthermore, it is emphasized that an early diagnosis of PLL is necessary to establish its true course and that the prognosis may be better than originally thought.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>2916562</pmid><doi>10.1002/ajh.2830300313</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0361-8609
ispartof Am. J. Hematol.; (United States), 1989-03, Vol.30 (3), p.188-189
issn 0361-8609
1096-8652
language eng
recordid cdi_proquest_miscellaneous_78858633
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects 550603 - Medicine- External Radiation in Therapy- (1980-)
Biological and medical sciences
BODY
DISEASES
Hematologic and hematopoietic diseases
HEMIC DISEASES
Humans
IMMUNE SYSTEM DISEASES
IRRADIATION
LEUKEMIA
Leukemia, Prolymphocytic - blood
Leukemia, Prolymphocytic - radiotherapy
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
lymphoproliferative disorder
Male
Medical sciences
MEDICINE
Middle Aged
NEOPLASMS
NUCLEAR MEDICINE
ORGANS
PATIENTS
polylymphocytic leukemia
RADIOLOGY
RADIOLOGY AND NUCLEAR MEDICINE
RADIOTHERAPY
SPLEEN
Spleen - radiation effects
splenic irradiation
THERAPY
title Splenic irradiation as primary therapy for prolymphocytic leukemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T10%3A17%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Splenic%20irradiation%20as%20primary%20therapy%20for%20prolymphocytic%20leukemia&rft.jtitle=Am.%20J.%20Hematol.;%20(United%20States)&rft.au=Kiss,%20A.&rft.aucorp=Univ.%20of%20Vienna%20(Austria)&rft.date=1989-03&rft.volume=30&rft.issue=3&rft.spage=188&rft.epage=189&rft.pages=188-189&rft.issn=0361-8609&rft.eissn=1096-8652&rft.coden=AJHEDD&rft_id=info:doi/10.1002/ajh.2830300313&rft_dat=%3Cproquest_osti_%3E78858633%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78858633&rft_id=info:pmid/2916562&rfr_iscdi=true